Bayer CropScience enters its Q1 FY27 results facing a complex monsoon season that has significantly shifted from last year's excess rainfall to a notable June deficit. Investors will be focused on whether the company's crop protection and seed businesses maintained their volume momentum despite this uneven start to the Kharif sowing cycle.
| Results date | August 05, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Previous quarter revenue | Rs. 1,914.6 Cr |
| Previous quarter PAT | Rs. 279.6 Cr |
| Market cap | Rs. 18,884.67 Cr |
| CMP | Rs. 4,202.0 |
The board will meet on August 5, 2026, to consider the unaudited financial results for the quarter ended June 30, 2026.
The company previously communicated that the record date for the final dividend of Rs. 60 per share for FY 2025-26 is August 5, 2026.
Bayer CropScience faces a challenging Q1 FY27 demand environment as the June rainfall deficit of -47% vs LPA likely compressed the early Kharif spray window compared to the 8% excess rainfall seen in 2025. While soybean prices reached a four-year high of Rs. 7,587 per 100 kg, providing a tailwind for farmer spending, the company must contend with broader chemical WPI inflation which rose to 9.87% in June. The customs duty exemption on agrochemical inputs active from April 2 to June 30, 2026, is expected to provide partial relief to margins, though the high Q1 FY26 base of Rs. 1,914.6 Cr in revenue sets a demanding benchmark for growth. Management's commentary on channel inventory levels and the impact of the June rainfall delay on volume uptake will be the primary focus of the upcoming disclosure.
Revenue and Profitability Trajectory: Monitoring whether the 17% YoY revenue growth achieved in Q1 FY26 was sustained in the face of June rainfall deficits.
Corn and Kharif Season Dynamics: Evaluating the performance of the core Corn seed portfolio amid challenging price signals.
Operational and Regulatory Updates: Tracking management's response to recent regulatory and strategic developments.
In Q1 FY26, Bayer CropScience reported revenue of Rs. 1,914.6 Cr, achieving 17% YoY growth driven by volume and an early onset of monsoon. The PAT for that period was Rs. 279.6 Cr, representing a 14.6% margin.
Bayer CropScience maintains a strong balance sheet with zero borrowings and a net cash position of Rs. 1,414.6 Cr as of the end of FY26. This liquidity provides the company with flexibility to manage seasonal working capital requirements.
In July 2026, Bayer AG acquired 53,54,030 shares (11.91% stake) from Bayer CropScience AG, increasing its direct holding to 20.34%. The aggregate promoter-group stake remains unchanged at 71.44%.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now